ConductScience.org, home

Paper41314850

Association between periprocedural change in serum renalase and microvascular obstruction in patients with STEMI after primary percutaneous coronary intervention: protocol for the ReMVOS prospective cohort study.

Chen Y and 15 others. BMJ Open, 2025. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. Association between periprocedural change in serum renalase and microvascular obstruction in patients with STEMI after primary percutaneous coronary intervention: protocol for the ReMVOS prospective cohort study. Papers, record 41314850. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41314850

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Association between periprocedural change in serum renalase and microvascular obstruction in patients with STEMI after primary percutaneous coronary intervention: protocol for the ReMVOS prospective cohort study.
PubMed
Journal
BMJ Open
PubMed
Year
2025
PubMed
Publication types
Journal Article, Clinical Trial Protocol
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-01-27
PubMed

Authors16

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Chen YYe
2Li RRuixuan
3Fu RRu
4Zhao LLinhttps://orcid.org/0000-0003-2994-2387
5Sheng ZZhehttps://orcid.org/0000-0002-6871-1736
6Xu KKai
7Liu JJia
8Huang WWei
9Wen JJuan
10Zeng LLixiong
11Ou ZZiweihttps://orcid.org/0000-0003-4654-8664
12Jiang ZZhou
13Liu YYing
14Wang YYuhong
15Jiang WWeihonghttps://orcid.org/0000-0001-8369-9694
16Li XXiaogang

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Percutaneous Coronary InterventionMajor topic
ST Elevation Myocardial InfarctionMajor topic
Postoperative ComplicationsMajor topic
Humans
Prospective Studies
Biomarkers
Microcirculation
Male
Female
Middle Aged
China
Observational Studies as Topic
Monoamine Oxidase

Source PubMed

Download CSV of topics

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT06669520Correlation of Blood Serum Renalase and Microcirculation Obstruction in Patients with Acute Myocardial Infarction After Primary Percutaneous Coronary InterventionDerived from the trialYes

Source ClinicalTrials.gov

Download CSV of trials

References49

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
133624185Predictors of Microvascular Reperfusion After Myocardial Infarction.Curr Cardiol Rep2021https://conductscience.org/library/papers/33624185PubMed
235586740Impact of Stress Hyperglycemia on No-Reflow Phenomenon in Patients with ST Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.Glob Heart2022https://conductscience.org/library/papers/35586740PubMed
330630613Elevated renalase levels in patients with acute coronary microvascular dysfunction - A possible biomarker for ischemia.Int J Cardiol2019https://conductscience.org/library/papers/30630613PubMed
438583174Visual Estimates of Coronary Slow Flow Are Not Associated With Invasive Wire-Based Diagnoses of Coronary Microvascular Dysfunction.Circ Cardiovasc Interv2024https://conductscience.org/library/papers/38583174PubMed
538283173Utility of electrocardiogram to predict the occurrence of the no-reflow phenomenon in patients undergoing primary percutaneous coronary intervention (PPCI): a systematic review and meta-analysis.Front Cardiovasc Med2023https://conductscience.org/library/papers/38283173PubMed
640835783External Comparator Studies: Performance of Four Missing Data-Handling Approaches, Stratified by Four Different Marginal Estimators.Drug Saf2025https://conductscience.org/library/papers/40835783PubMed
731617010Coronary microvascular obstruction: the new frontier in cardioprotection.Basic Res Cardiol2019https://conductscience.org/library/papers/31617010PubMed
838400562The predictive value of laboratory parameters for no-reflow phenomenon in patients with ST-elevation myocardial infarction following primary percutaneous coronary intervention: A meta-analysis.Clin Cardiol2024https://conductscience.org/library/papers/38400562PubMed
929020248
Relationship between microvascular obstruction and adverse events following primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: an individual patient data pooled analysis from seven randomized trials.
Eur Heart J2017https://conductscience.org/library/papers/29020248PubMed
1025497549Renalase is a novel target gene of hypoxia-inducible factor-1 in protection against cardiac ischaemia-reperfusion injury.Cardiovasc Res2015https://conductscience.org/library/papers/25497549PubMed
1115881532Standardizing the definition of hyperenhancement in the quantitative assessment of infarct size and myocardial viability using delayed contrast-enhanced CMR.J Cardiovasc Magn Reson2005https://conductscience.org/library/papers/15881532PubMed
1240622620Predicting MRI-diagnosed microvascular obstruction and its long-term impact after acute myocardial infarction.Clin Res Cardiol2025https://conductscience.org/library/papers/40622620PubMed
1330032783Research Techniques Made Simple: Sample Size Estimation and Power Calculation.J Invest Dermatol2018https://conductscience.org/library/papers/30032783PubMed
1415841207Renalase is a novel, soluble monoamine oxidase that regulates cardiac function and blood pressure.J Clin Invest2005https://conductscience.org/library/papers/15841207PubMed
1537052556Impact of Persistent Microvascular Obstruction Late After STEMI on Adverse LV Remodeling: A CMR Study.JACC Cardiovasc Imaging2023https://conductscience.org/library/papers/37052556PubMed
1632689822Redefining Adverse and Reverse Left Ventricular Remodeling by Cardiovascular Magnetic Resonance Following ST-Segment-Elevation Myocardial Infarction and Their Implications on Long-Term Prognosis.Circ Cardiovasc Imaging2020https://conductscience.org/library/papers/32689822PubMed
179737521Magnitude and time course of microvascular obstruction and tissue injury after acute myocardial infarction.Circulation1998https://conductscience.org/library/papers/9737521PubMed
1818299506Catecholamines regulate the activity, secretion, and synthesis of renalase.Circulation2008https://conductscience.org/library/papers/18299506PubMed
1925966766Renalase protects the cardiomyocytes of Sprague-Dawley rats against ischemia and reperfusion injury by reducing myocardial cell necrosis and apoptosis.Kidney Blood Press Res2015https://conductscience.org/library/papers/25966766PubMed
2032916539Roles and mechanisms of renalase in cardiovascular disease: A promising therapeutic target.Biomed Pharmacother2020https://conductscience.org/library/papers/32916539PubMed

See all 49 referencesDownload CSV of references

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
RNLS55328PubTator's text mininghttps://conductscience.org/library/genes/55328

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Comments and corrections
  • Cited by
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41314850

GET https://conductscience.org/api/papers/v1/41314850/references?page=2